ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
IN8bio Inc

IN8bio Inc (INAB)

0.3251
0.0161
( 5.21% )
Updated: 14:49:58

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.3251
Bid
0.3252
Ask
0.3296
Volume
513,635
0.303 Day's Range 0.3398
0.217 52 Week Range 2.48
Market Cap
Previous Close
0.309
Open
0.303
Last Trade
100
@
0.3251
Last Trade Time
14:49:58
Financial Volume
$ 167,805
VWAP
0.326701
Average Volume (3m)
1,212,006
Shares Outstanding
72,483,253
Dividend Yield
-
PE Ratio
-0.80
Earnings Per Share (EPS)
-0.41
Revenue
-
Net Profit
-30.01M

About IN8bio Inc

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $0.31. Over the last year, IN8bio shares have traded in a share price range of $ 0.217 to $ 2.48.

IN8bio currently has 72,483,253 shares outstanding. The market capitalization of IN8bio is $22.40 million. IN8bio has a price to earnings ratio (PE ratio) of -0.80.

INAB Latest News

IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc.Β (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...

IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting

50% of patients who received repeated doses (n=10) remained alive and in remission beyond the expected median overall survival (OS) from standard-of-care Stupp regimen while none of the patients...

IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...

IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...

IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01524.904808002580.30990.410.2915452860.34620548CS
4-0.0249-7.114285714290.350.410.296386170.33683781CS
120.00511.593750.320.55660.21712120060.382373CS
26-1.0749-76.77857142861.41.740.2177991360.52772485CS
52-0.6749-67.4912.480.2176496830.86258054CS
156-6.7649-95.41466854727.097.180.2176815842.07562611CS
260-9.6749-96.7491010.3190.2176126952.12994484CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LDTCLeddarTech Holdings Inc
$ 1.55
(399.68%)
257.6M
MGXMetagenomi Inc
$ 4.09
(121.08%)
51.72M
ZEOZeo Energy Corporation
$ 2.58
(96.95%)
46.57M
HUIZHuize Holding Ltd
$ 5.05
(87.01%)
3.05M
GXAIGaxos ai Inc
$ 4.4801
(72.31%)
102.33M
BIOABioAge Labs Inc
$ 5.005
(-75.09%)
8.41M
UPCUniverse Pharmaceuticals Inc
$ 1.345
(-60.32%)
4.76M
RADXRadiopharm Theranostics Ltd
$ 10.00
(-47.09%)
98.52k
CYNCYNGN Inc
$ 3.94
(-33.89%)
873.28k
BSGMBioSig Technologies Inc
$ 1.01
(-28.87%)
235.02k
RIMEAlgorhythm Holdings Inc
$ 0.1198
(30.22%)
263.66M
LDTCLeddarTech Holdings Inc
$ 1.55
(399.68%)
257.62M
DUOFangDD Network Group Ltd
$ 0.8069
(39.55%)
251.32M
UOKAMDJM Ltd
$ 0.2185
(50.38%)
228.25M
LCIDLucid Group Inc
$ 2.5805
(12.20%)
149.45M

INAB Discussion

View Posts
glenn1919 glenn1919 2 months ago
INAB....................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 2 months ago
IN8bio Announces Pricing of $12.4 Million Private Placement
πŸ‘οΈ0
BurgerKing82 BurgerKing82 3 months ago
Hello
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 months ago
https://x.com/MSollender/status/1831422943987167269
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
INAB new 52 week low
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Tyrus603 Tyrus603 8 months ago
Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.
πŸ‘οΈ0
Laster Laster 8 months ago
Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.
πŸ‘οΈ0
Invest-in-America Invest-in-America 8 months ago
INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
INAB under $2
πŸ‘οΈ0
murocman murocman 12 months ago
Surprised how much this has tanked in light of stellar data?

Murocman
πŸ‘οΈ0
murocman murocman 12 months ago
Outstanding data and financing in place to boot!

Should move up!

Murocman
πŸ‘οΈ0
Awl416 Awl416 12 months ago
IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB under $2
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
INAB new 52 week low
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
like this
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
looks good
πŸ‘οΈ0
The Night Stalker The Night Stalker 1 year ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
dip
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
nice
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
strong chart
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
reaDY
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
reaDY
πŸ‘οΈ0
Mr Wick Mr Wick 2 years ago
New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
nice
πŸ‘οΈ0
MrMocha MrMocha 2 years ago
I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!
👍️ 1
Mr Wick Mr Wick 2 years ago
New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.
👍️ 1
The Night Stalker The Night Stalker 2 years ago
right on
πŸ‘οΈ0
The Night Stalker The Night Stalker 2 years ago
strong as hell
πŸ‘οΈ0
Trons Trons 2 years ago
Headed to $20 on cancer developments
πŸ‘οΈ0
Jess070283 Jess070283 2 years ago
Uh oh Shorts I’m trouble….
πŸ‘οΈ0
trendzone trendzone 2 years ago
Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.
πŸ‘οΈ0
Jess070283 Jess070283 2 years ago
Loading this dip for the rip…
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target
πŸ‘οΈ0
subslover subslover 2 years ago
Love your scanner! :)
πŸ‘οΈ0
2020Benzo 2020Benzo 2 years ago
Did they just post same Orphan Drug news twice in a row it’s sane PR !
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
sub $2
πŸ‘οΈ0
surf1944 surf1944 2 years ago
https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1
πŸ‘οΈ0
ringo1 ringo1 2 years ago
Time to take some profits
πŸ‘οΈ0
Hercules1 Hercules1 2 years ago
It hit $3.95.

$4 break is coming.


$5 quite possible today.
πŸ‘οΈ0
Hercules1 Hercules1 2 years ago
Total beast.

Next stop $4.

And then $5.
πŸ‘οΈ0
Awl416 Awl416 2 years ago
Impressive day
πŸ‘οΈ0
Jess070283 Jess070283 2 years ago
What a beast!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock